Trial Profile
Oral Navelbine Carboplatin Versus Gefitinib Neoadjuvant Therapy for Resectable EGFR Mutation Positive Stage Ⅱ-ⅢA NSCLC, Prospective, Randomized, Multicenter, Phase Ⅲ Clinical Trial
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Carboplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Jul 2017 New trial record